Fri, Apr 18, 2014, 1:31 PM EDT - U.S. Markets closed for Good Friday

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • philfilm777 philfilm777 Mar 7, 2007 8:53 AM Flag

    Settlement

    TRCA/INSM: Settlement, License and Development Agreement w/Genentech
    08:03 a.m. 03/07/2007 Provided by
    Ridgeland, MS, MAR 07, 2007 (EventX/Knobias.com via COMTEX) -- By Fain Hughes, fhughes@knobias.com
    Tercica, Inc. (TRCA) and Insmed Incorporated (INSM) announced that Tercica, Insmed and Genentech, Inc. (DNA) have entered a Settlement, License and Development Agreement that resolves all outstanding litigation between the companies, including the patent infringement suits brought by Tercica and Genentech against Insmed in the United States and United Kingdom, and the unfair business practices suit. Tercica and Genentech have waived the damages award by the jury in the U.S. patent infringement litigation.
    Insmed will no longer provide IPLEX(TM) to patients with severe Primary IGF-1 Deficiency and other short stature indications and will withdraw its IPLEX marketing authorization application for severe Primary IGF-1 Deficiency in the European Union.
    Through licensing and development rights granted by Tercica and Genentech, Insmed will have freedom to operate regarding the manufacture, development and commercialization of IPLEX for certain non-short stature indications including severe insulin resistance, myotonic muscular dystrophy and HIV associated adipose redistribution syndrome (HARS), subject to opt-in rights and royalty provisions for Tercica and Genentech.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
13.41+0.88(+7.02%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT
WisdomTree Investments, Inc.
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT